Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter?
Type 2 diabetes mellitus
impaired fasting glucose
impaired glucose tolerance
sex
thyroid nodules
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
30 May 2022
30 May 2022
Historique:
received:
26
03
2022
revised:
17
05
2022
accepted:
28
05
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
(1) Background: Glucose metabolism derangements (GMD) and thyroid nodules (TNs) are the most frequent endocrine disorders, and their relationship is still controversial; little evidence is reported regarding sex differences. We aim to evaluate the association between GMDs and TNs according to sex and the sex differences in glucose metabolism and insulin sensitivity (IS). (2) Methods: We evaluated 342 patients (268 females and 74 males) at high GMD risk undergoing an oral glucose tolerance test and a thyroid ultrasound. (3) Results: The TN prevalence was 61% (
Identifiants
pubmed: 35743689
pii: jpm12060903
doi: 10.3390/jpm12060903
pmc: PMC9225610
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : University of Ferrara
ID : FAR 2019, 2020, 2021
Références
Mediators Inflamm. 2017;2017:8481049
pubmed: 28607535
Int J Endocrinol. 2019 Nov 26;2019:9376768
pubmed: 31885566
J Clin Endocrinol Metab. 1955 Oct;15(10):1270-80
pubmed: 13263417
Br J Nutr. 2008 May;99(5):931-40
pubmed: 17977473
Diabetes Res Clin Pract. 2018 Apr;138:271-281
pubmed: 29496507
Front Endocrinol (Lausanne). 2021 Sep 16;12:730279
pubmed: 34603208
Obesity (Silver Spring). 2012 Oct;20(10):1966-73
pubmed: 22282046
Endocr Rev. 2013 Jun;34(3):309-38
pubmed: 23460719
Trends Endocrinol Metab. 2011 Jan;22(1):24-33
pubmed: 21109497
Diabet Med. 2002 Sep;19(9):708-23
pubmed: 12207806
Eur J Clin Invest. 2009 Aug;39(8):699-706
pubmed: 19601965
Colomb Med (Cali). 2019 Dec 30;50(4):239-251
pubmed: 32476690
Cell Prolif. 2007 Dec;40(6):921-35
pubmed: 18021179
Arch Endocrinol Metab. 2017 Dec;61(6):575-583
pubmed: 29412382
Best Pract Res Clin Endocrinol Metab. 2008 Dec;22(6):901-11
pubmed: 19041821
Endocr Rev. 2016 Jun;37(3):278-316
pubmed: 27159875
Thyroid. 2022 May;32(5):571-580
pubmed: 35317620
Mol Cell Endocrinol. 1989 May;63(1-2):67-74
pubmed: 2473935
Diabetes Care. 2021 Jan;44(Suppl 1):S15-S33
pubmed: 33298413
Endocrine. 2018 May;60(2):339-347
pubmed: 28836113
J Endocrinol. 1996 Nov;151(2):185-94
pubmed: 8958778
Medicine (Baltimore). 2017 Nov;96(47):e8230
pubmed: 29381912
Thyroid. 2008 Apr;18(4):461-4
pubmed: 18346005
Front Endocrinol (Lausanne). 2021 Sep 21;12:736972
pubmed: 34621243
Diabetes Care. 2015 Nov;38(11):e176-7
pubmed: 26384388
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Med Hypotheses. 2010 Jan;74(1):35-6
pubmed: 19720470
Coron Artery Dis. 1998;9(12):799-803
pubmed: 9894924
J Endocrinol Invest. 2004 Jan;27(1):31-6
pubmed: 15053240
J Clin Endocrinol Metab. 2003 Jun;88(6):2404-11
pubmed: 12788835
Eur J Endocrinol. 2009 Oct;161(4):599-605
pubmed: 19633072
Curr Med Sci. 2019 Aug;39(4):576-581
pubmed: 31346993
Diabetologia. 2020 Mar;63(3):453-461
pubmed: 31754750
Risk Manag Healthc Policy. 2021 Dec 07;14:4875-4882
pubmed: 34908885